Literature DB >> 17425495

Dementia syndromes: evaluation and treatment.

Kevin R Scott1, Anna M Barrett.   

Abstract

As our population ages, diseases affecting memory and daily functioning will affect an increasing number of individuals, their families and the healthcare system. The social, financial and economic impacts will be profound. This article provides an overview of current dementia syndromes to assist clinicians in evaluating, educating and treating these patients.

Entities:  

Mesh：

Year:  2007        PMID： 17425495      PMCID： PMC2536654          DOI： 10.1586/14737175.7.4.407

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


  131 in total

1.  The Mini-Cog as a screen for dementia: validation in a population-based sample.

Authors:  Soo Borson; James M Scanlan; Peijun Chen; Mary Ganguli
Journal:  J Am Geriatr Soc       Date:  2003-10       Impact factor: 5.562

Review 2.  The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.

Authors:  B McGuinness; S Todd; P Passmore; R Bullock
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 3.  Donepezil for mild cognitive impairment.

Authors:  J Birks; L Flicker
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

4.  Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care.

Authors:  M C Reid; Peter H Van Ness; Keith A Hawkins; Virginia Towle; John Concato; Zhenchao Guo
Journal:  J Geriatr Psychiatry Neurol       Date:  2006-06       Impact factor: 2.680

Review 5.  Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials.

Authors:  Christopher C Butler; Josep Vidal-Alaball; Rebecca Cannings-John; Andrew McCaddon; Kerenza Hood; Alexandra Papaioannou; Ian Mcdowell; Andrew Goringe
Journal:  Fam Pract       Date:  2006-04-03       Impact factor: 2.267

6.  Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Authors:  S Salloway; S Ferris; A Kluger; R Goldman; T Griesing; D Kumar; S Richardson
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

7.  The decreasing prevalence of reversible dementias: an updated meta-analysis.

Authors:  A Mark Clarfield
Journal:  Arch Intern Med       Date:  2003-10-13

Review 8.  Dementia in Parkinson's disease: cause and treatment.

Authors:  Murat Emre
Journal:  Curr Opin Neurol       Date:  2004-08       Impact factor: 5.710

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Clinicopathological correlates in frontotemporal dementia.

Authors:  John R Hodges; R Rhys Davies; John H Xuereb; Barney Casey; Melissa Broe; Thomas H Bak; Jillian J Kril; Glenda M Halliday
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422
View more
  22 in total

1.  Antidepressant and antipsychotic prescribing in primary care for people with dementia.

Authors:  Neil Drummond; Lynn McCleary; Elizabeth Freiheit; Frank Molnar; William Dalziel; Carole Cohen; Diana Turner; Rebecca Miyagishima; James Silvius
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

2.  Serious games for screening pre-dementia conditions: from virtuality to reality? A pilot project.

Authors:  Chiara Zucchella; Elena Sinforiani; Cristina Tassorelli; Elena Cavallini; Daniela Tost-Pardell; Sergi Grau; Stefania Pazzi; Stefano Puricelli; Sara Bernini; Sara Bottiroli; Tomaso Vecchi; Giorgio Sandrini; Giuseppe Nappi
Journal:  Funct Neurol       Date:  2014 Jul-Sep

3.  Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases.

Authors:  Valery Filippov; Minwoo Andrew Song; Kangling Zhang; Harry V Vinters; Spencer Tung; Wolff M Kirsch; Jun Yang; Penelope J Duerksen-Hughes
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status.

Authors:  Jagan A Pillai; Lei Kou; James Bena; Lisa Penn; James B Leverenz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 5.  Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.

Authors:  Manish Kumar; Nitin Bansal
Journal:  Mol Neurobiol       Date:  2021-10-26       Impact factor: 5.682

Review 6.  DNA methylation and cognitive aging.

Authors:  Xiangru Xu
Journal:  Oncotarget       Date:  2015-06-10

7.  Psychometric Evaluation of the Cognitive State Test (COST) in a Sample of Iranian Elderly People.

Authors:  Mohammad-Sajjad Lotfi; Zahra Tagharrobi; Khadijeh Sharifi; Javad Abolhasani
Journal:  Iran Red Crescent Med J       Date:  2016-01-05       Impact factor: 0.611

8.  Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2-ARE Pathway.

Authors:  Ibraheem Husain; Mohd Akhtar; Tushar Madaan; Divya Vohora; Malik Z Abdin; Mohammad Islamuddin; Abul K Najmi
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

9.  Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice.

Authors:  Kunal Khurana; Manish Kumar; Nitin Bansal
Journal:  Neurotox Res       Date:  2021-03-15       Impact factor: 3.911

10.  A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease.

Authors:  Hongjiu Zhang; Fan Zhu; Hiroko H Dodge; Gerald A Higgins; Gilbert S Omenn; Yuanfang Guan
Journal:  Gigascience       Date:  2018-07-01       Impact factor: 6.524
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.